A new wearable removes the guesswork from breastfeeding
While breastfeeding offers numerous benefits for both mother and baby, one challenge has persisted: It’s nearly impossible to know how much milk a baby is consuming.
ENRICH Office’s Health Innovations Symposium showcases Rice-TMC biomedical collaboration ecosystem
Rice’s ENRICH Office hosted a two-day symposium April 24-25 at Helix Park highlighting the encompassing range of biomedical research at the university and the network of collaborations with institutions across the Texas Medical Center.
Machine learning powers new approach to detecting soil contaminants
A team of researchers at Rice and Baylor College of Medicine has developed a new strategy for identifying hazardous pollutants in soil ⎯ even ones that have never been isolated or studied in a lab.
Biotech trailblazers Robert Langer, Robert Ruffolo to headline RBL LLC launch event May 5
The Rice Biotech Launch Pad and RBL LLC will celebrate the official launch and lab opening of RBL LLC May 5 with a program featuring biotech pioneers Robert Langer and Robert Ruffolo.
RBL LLC welcomes Devyn Smith to board of directors
RBL LLC announced the appointment of Devyn Smith to its board of directors.
Global innovation takes center stage at Rice as undergraduate teams tackle health inequities
At the Rice360 Institute for Global Health Technologies’ 15th annual Undergraduate Design Competition, the future of global health innovation was on full display.
Rice Biotech Launch Pad welcomes David Allison to external advisory board
The Rice Biotech Launch Pad, a Houston-based accelerator focused on expediting the translation of Rice University’s health and medical technology discoveries into cures, today announced the addition of David Allison to its external advisory board.
Cancer-fighting implant shows promise in treating melanoma, pancreatic and colorectal tumors
A team of researchers from the Rice Biotech Launch Pad has developed an implantable “cytokine factory” that safely triggers potent immune responses against hard-to-treat cancers, including metastatic melanoma, pancreatic and colorectal tumors.
New Rice institute to study lifetime health impacts and develop targeted interventions
Rice University has launched the Institute of Health Resilience and Innovation.
Bioelectronic devices, neural interfaces, biosensors and AI hardware are now easier to make thanks to a streamlined method for fabricating a key material.
Rice Biotech Launch Pad and RBL LLC to celebrate official launch and lab opening
The Rice Biotech Launch Pad and RBL LLC will hold an event to celebrate the official launch and lab opening of RBL LLC May 5, following a Rice presidential lecture delivered by Robert Langer Jr. The launch event, held at Helix Park, will also feature a keynote a keynote presentation by Robert Ruffolo Jr.
Rice’s Kaiyuan Yang and his team recently unveiled a first-of-its-kind authentication protocol for wireless, battery-free, ultraminiaturized implants that ensures these devices remain protected while still allowing emergency access.
Rice statistician earns CPRIT award to advance AI-powered precision medicine for prostate cancer
Rice statistician Erzsébet Merényi is part of a team of researchers awarded $1 million by the Cancer Prevention and Research Institute of Texas to develop AI tools that can identify lethal forms of prostate cancer earlier and improve treatment selection.
A recent symposium organized by the ENRICH office and the Rice Neuroengineering Initiative as part of the Meeting of the Minds NeuroNetworking Series explored ethics and policy in brain science today, including in the context of psychedelic-assisted therapy.
A research team led by Rice's Yang Gao has uncovered new insights into the molecular mechanisms of ADAR1.